nicht mehr verfügbar

NBP1-18963C ONECUT2 (OC2-1D11) - hepatic duct cell marker Antikörper

See related secondary antibodies

Search for all "ONECUT2 (OC2-1D11) - hepatic duct cell marker"

Kurzübersicht

Rat anti Mouse ONECUT2 (OC2-1D11) - hepatic duct cell marker OC2-1D11

NBP1-18963C

Produktbeschreibung für ONECUT2 (OC2-1D11) - hepatic duct cell marker

Rat anti Mouse ONECUT2 (OC2-1D11) - hepatic duct cell marker OC2-1D11.
Presentation: DyLight649
Product is tested for Frozen Sections, Flow Cytometry, Paraffin Sections.

Produktdaten von ONECUT2 (OC2-1D11) - hepatic duct cell marker

Produkt-Kategorie Primärantikörper
Menge 0.1 ml
Synonyme anti-oval cell-2 antibody
Präsentation DyLight649
Reaktivität Ms
Anwendungen C, F, P
Klonalität Monoclonal
Klon OC2-1D11
Wirt Rat
Isotype IgG1
Shipping to Not USA/Canada
PDF datasheet Datenblatt ansehen
Hersteller Novus Biologicals Inc.

Datenblatt-Auszug

Immunogen
Immunogen:
Nonparenchymal cells from DDC-treated mice
Add. information Research Areas: Stem Cell Markers
Anwendung flow cytometry / FACS analysis, Immunohistochemistry-Frozen, This antibody is useful for Immunohistochemistry-frozen acetone fixed sections* and Flow cytometry, flow cytometry / FACS analysis 1:1, Immunohistochemistry-Frozen 1:100
Background Facultative liver stem cell activation was originally described in the rat, where chemical damage and partial hepatectomy caused the emergence of a new cell type, the oval cell. These cells are thought to be bipotential progenitors capable of yielding both hepatocytes and bile ducts (1). To properly determine the molecular regulation of the progenitor process, appropriate markers are needed to identify and isolate cells that emerge during the oval cell response.
Concentration 1 mg/ml
Storage Store at 4C. Do not freeze.
Format
Label:
DyLight 649
DyLight649
Purification:
Tissue culture supernatant
Buffer System:
No Preservative
Purity:
Tissue culture supernatant
Specificity
Specificity:
Specific for proliferating hepatic duct cells.
Species:
Mouse

Accessory Products

  • LinkedIn